Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5'-Nucleotidase domain containing 1 (NT5DC1) is a human protein-coding gene that encodes an enzyme classified within the 5'-nucleotidase family, specifically belonging to the HAD (haloacid dehalogenase) superfamily[4][5]. It exhibits hydrolase and 5'-nucleotidase activity, likely involved in the hydrolysis of nucleotide monophosphates, thus participating in intracellular nucleotide metabolism[3][4]. While its precise biochemical substrate and physiological role remain uncertain, recent studies have linked NT5DC1 (and the NT5DC family) to cancer biology, most notably breast cancer, where altered expression correlates with clinicopathological features and patient outcomes[3]. NT5DC1 is also associated with rare inherited diseases like metaphyseal chondrodysplasia, Schmid type, and Ritscher-Schinzel syndrome 1[4]. There are currently no known drugs directly targeting NT5DC1, and its candidacy as a drug target remains under investigation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5'-nucleotidase domain containing 1 (NT5DC1).